HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Retia Medical Raises $15 Million Series B
Financing round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office notes Retia Medical.
Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device
The Vascular Dynamics MobiusHD device is designed to provide interventionalists with a minimally-invasive transcatheter approach to help treat patients suffering from continued heart failure problems despite pharmaceutical therapy.
Calyxo Raises $32.7 Million in Series C Financing
Calyxo notes the investment round will fund further product development and expansion of their Team.
PhysioMedics Poised for Growth Through Capital Fundraise Following CEO Appointment
Edinburgh-based PhysioMedics secured equity and grant funding totalling £1.5m from Archangels, Scottish Enterprise and Innovate UK.
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.
Centerline Biomedical Raises $33 Million in Series B Financing
Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.
MicroTransponder Raises $53M
MicroTransponder plans to use the funds to commercialize the Vivistim® Paired VNS™ System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.
Artio Medical Closes $28M in Additional Series A Financing
Artio Medical notes the funds will be used to support US commercialization efforts for the recently cleared Solus Gold™ Embolization Device and to accelerate the development of Artio's broad portfolio of products.
Lauxera Capital Partners Invests €10m In Matrix Requirements
Founded in 2014, Matrix Requirements supports the R&D, Regulatory Affairs and Quality departments of MedTech companies by providing specialized digital tools for medical device design, traceability, quality management and regulatory compliance.
